Plasma phospholipids exchange on to the erythrocyte membrane Lipids: With different age groups and anti diabetic therapy.

Abstract

Dyslipideamia is a major cause, observed in type 2 diabetic subjects with micro vascular complications and membrane functional alteration is very common. The relative amount of phospholipids and cholesterol is responsible entity for normal function and membrane fluidity and rigidity. Many research studies reported on plasma lipid anomaly even on anti diabetic agents and also our earlier laboratory study supports, influence of anti diabetic therapy on plasma lipids and its relation to lipid alteration in erythrocyte membrane of diabetic subjects.